Novandi Chemistry

What Novandi Chemistry does

Novandi Chemistry AB is a privately held Swedish specialty chemistry services company headquartered in Södertälje (Biovation Park Telge) that provides custom radiosynthesis and catalog sales of isotopically labeled compounds — primarily tritium ([³H]), carbon-14 ([¹⁴C]), and stable isotope labeled (SIL) molecules — to life science researchers and pharmaceutical companies worldwide. The company operates a state-of-the-art radiosynthetic and radioanalytical laboratory equipped with LC-MS, HPLC-Radiochemical flow, HPLC-UV, TLC-Radioscan, and NMR instrumentation, supported by a chemical inventory of more than 15,000 reagents and building blocks that enables rapid initiation of multi-step custom synthesis projects.

The company's product surface consists of two core offerings: a Custom Radiosynthesis Service providing de novo multi-step synthesis, fit-for-purpose label placement, route scouting, radiosynthesis development, long-term compound storage, continuous quality control, and third-party international door-to-door shipment of radiolabeled substances; and a Radiochemical Catalog of over 100 novel and exclusive isotopically labeled tool compounds spanning GPCR ligands, transporter inhibitors, signaling inhibitors, ion channel modulators, and labeling reagents. Exclusive inbound licensing agreements with Clino Ltd (Japan) for [³H]THK-5117 and Navidea Biopharmaceuticals (USA) for [³H]AZD2184 anchor the catalog with patented PET radiotracers.

Novandi operates a B2B professional services and product sales model with project-based quote pricing for custom synthesis and inquiry-based pricing for catalog items. The company is licensed by the Swedish Radiation Safety Authority (SSM) and the Swedish Medical Products Agency, enabling it to manufacture and handle controlled radiolabeled substances. Distribution is direct-to-customer via email-initiated engagement, with international shipping to North America, Europe, and Asia; in October 2023 it added Zettle by PayPal card payment capability for purchases up to approximately $4,500. Customer acquisition leans on scientific conference presence (e.g., Neuroreceptor Mapping 2026) and a direct website with catalog search, and the firm maintains SwedenBio industry association membership.

Name

Novandi Chemistry

Legal name

Novandi Chemistry AB

Website

https://novandi.se

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Novandi Chemistry AB is a Swedish specialty radiochemistry services firm providing custom radiosynthesis and catalog sales of tritium, carbon-14, and stable isotope-labeled compounds to global life science researchers and pharmaceutical companies.

Ownership category

akta.pro rank

Product category

Custom Radiochemistry Services

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Pharmaceutical and Medicine Manufacturing (3254)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Radiopharmaceutical Manufacturing & CDMO (Synthesis, GMP, Packaging, QA/QC) (EUAKAIAC)

akta.pro secondary industries

Medical Radioisotope Production (Reactor/Cyclotron, Mo-99/Tc-99m, I-131, Lu-177, etc.) (EUAKAIAA), Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)

Keywords

• Custom radiosynthesis services
• Isotope labeled compounds
• Tritium carbon-14 labeling
• Radiolabeled tool compounds
• ADME imaging reagents

Headquarters

HQ city

Södertälje

HQ country

Sweden

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Custom Radiosynthesis Services: Comprehensive custom synthesis service for tritium, carbon-14, and stable labeled molecules. Includes route scouting, synthesis development, compound storage, quality control, and third-party international door-to-door shipments.
2. Radiochemical Catalog Products: Sale of novel and exclusive isotopically labeled tool compounds for laboratory research including tritium, carbon-14, and stable isotope labeled (SIL) products.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Novandi Chemistry provides de novo multi-step custom radiosynthesis of tritium, carbon-14, and stable isotope-labeled molecules for pharmaceutical and life science research customers. The company also supplies a catalog of novel isotopically labeled tool compounds, and offers end-to-end services covering route scouting, synthesis development, quality control, long-term compound storage, and international door-to-door shipment of radiolabeled substances.

Product overview

Novandi Chemistry is a global provider of tritium, carbon-14, and stable labeling chemistry services. The company operates two core offerings: a Custom Radiosynthesis Service providing comprehensive de novo multi-step synthesis of radiolabeled molecules with quality control and storage capabilities, and a Radiochemical Catalog offering novel isotopically labeled tool compounds (tritium [³H], carbon-14 [¹⁴C], and stable isotope labeled [SIL] products) for laboratory research applications including GPCR ligands, transporter inhibitors, and ion channel modulators.

Differentiator

Problem solved

Functional benefit

Products and services

• Custom Radiosynthesis Service Comprehensive de novo multi-step custom synthesis service for tritium, carbon-14, and stable labeled molecules, including route scouting, fit-for-purpose label placement for ADME and imaging studies, radiosynthesis development, compound storage, continuous quality control, and third-party international door-to-door shipments. Targeted at pharmaceutical and biotech companies conducting drug development studies.
• Radiochemical Catalog Catalog of novel and exclusive isotopically labeled tool compounds for laboratory research, including tritium (³H), carbon-14 (¹⁴C), and stable isotope labeled (SIL) products such as GPCR ligands, transporter inhibitors, signaling inhibitors, and ion channel modulators. Products are supplied with short notice and can be shipped internationally.

Quantifiable outcome

• Each radiolabeling and synthesis assignment is accompanied by a complete analysis report and Certificate of Analysis

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

One partnership is on record.

• SwedenBiominorOthersSwedenBio membership indicating membership in the Swedish life science/biotech industry association.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Pharmaron: China-headquartered full-service CRO/CDMO offering radiolabeled chemistry (via Quotient), drug substance, and integrated drug development services. Competes with Novandi primarily on larger pharma ADME programs requiring integrated CDMO capabilities.
• Revvity (formerly PerkinElmer Life Sciences): Global life sciences instrumentation and reagents company with radiolabeled chemistry, radio-HPLC standards, and custom synthesis offerings as part of a much broader portfolio. Competes with Novandi on radiolabeled standards and reference compounds but is not a focused custom radiosynthesis CDMO.
• Merck (Sigma-Aldrich) Life Science: Diversified life science supplier offering stable isotope-labeled compounds, deuterated reagents, and selected radiolabeled products. Overlaps with Novandi's SIL catalog but does not typically compete in custom tritium/C-14 radiosynthesis at project scale.

Direct peers

• ABX Advanced Biochemical Compounds: German specialty producer of radiolabeled compounds (including C-14, tritium, F-18 precursors) and PET precursors. Directly comparable niche CDMO focused on isotopically labeled fine chemicals for research and clinical use.
• Moravek Biochemicals: US-based CDMO specializing in custom radiosynthesis of carbon-14 and tritium-labeled compounds for ADME and drug development. Directly comparable in scope (custom radiolabeled synthesis + catalog of labeled compounds) and customer base.
• Curachem: Specialty chemistry CDMO offering custom radiosynthesis of C-14 and tritium-labeled compounds alongside related stable isotope work. Direct overlap with Novandi's core custom radiosynthesis service.
• Vitrax: California-based custom radiosynthesis CDMO offering C-14, tritium, and stable isotope-labeled compounds with QC and regulatory support for pharma metabolism studies. Closely matches Novandi's custom service model and customer profile.
• Toronto Research Chemicals: Canadian catalog and custom supplier of high-purity research chemicals, including isotopically labeled reference standards and tool compounds used in neuroscience and drug discovery. Comparable in catalog breadth for labeled tool compounds serving academic and pharma researchers.
• Cambridge Isotope Laboratories (CIL): Global leader in stable isotope-labeled compounds and a major supplier of C-13, deuterated, and other isotope-labeled research products. Overlaps directly with Novandi's stable-label custom synthesis and SIL catalog offerings for life science research.
• Quotient Bioresearch (Pharmaron): Quotient Bioresearch, now part of Pharmaron, is one of the largest custom radiosynthesis and radiolabeled chemistry CDMOs serving pharma ADME and metabolism studies globally. It is the most direct large-scale competitor to Novandi's custom tritium and C-14 synthesis service.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/novandi-chemistry-ab

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Novandi Chemistry